To explore whether GFAT1 was associated with tumor progression in clinical gastric cancer cases, a tissue microarray containing 211 gastric cancer samples was employed in immunohistochemistry assay to examine the relationship between GFAT1 expression and clinicopathological characteristics. The gene discussed is GFPT1; the disease is gastric cancer.